Adjuvant chemotherapy seems beneficial for invasive intraductal papillary mucinous neoplasms

European Journal of Surgical Oncology

Volumn 39, Issue 4, 2013, Pages 396-403

  Caponi, S ^a,b   Vasile, E ^a   Funel, N ^b   De Lio, N ^c   Campani, D ^b   Ginocchi, L ^a,b   Lucchesi, M ^a,b   Caparello, C ^a,b   Lencioni, M ^a   Cappelli, C ^b,c   Costa, F ^b,c   Pollina, L ^c   Ricci, S ^a   Mosca, F ^b   Falcone, A ^a,b   Boggi, U ^b,c  

^a ISTITUTO TOSCANO TUMORI   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c UNIVERSITY HOSPITAL OF PISA   (Italy)

Author keywords

Adjuvant chemotherapy; Gemcitabine; Intraductal papillary mucinous neoplasms; Pancreatic cancer; Prognostic factors

Indexed keywords

GEMCITABINE;

ADJUVANT CHEMOTHERAPY; ADULT; AGED; ARTICLE; CANCER GRADING; CANCER INVASION; CANCER PROGNOSIS; CANCER SURGERY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADENOCARCINOMA, MUCINOUS; ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; CHEMOTHERAPY, ADJUVANT; DEOXYCYTIDINE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; ITALY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84875215514     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2012.12.005     Document Type: Article

References (52)

1. K. Ohhashi, Y. Murakami, and T. Takekoshi Four cases of mucin producing cancer of the pancreas on specific findings of papilla of vater Prog Diag Endosc 20 1982 348 351
2. G. Kloppel, E. Solcia, and D.S. Longnecker Histological typing of tumors of the exocrine pancreas World Health Organization International histological classification of tumors 2nd ed. 1996 Springer Berlin 15 21
3. G. Zamboni, G. Kloppel, R.H. Hruban, D.S. Longnecker, and G. Adler Mucinous cystic neoplasms of the pancreas S.R. Hamilton, L.A. Aaltonen, World Health Organization classification of tumors 2000 IARC Press Lyon, France 234 236
4. D.S. Longnecker, G. Adler, and R.H. Hruban Intraductal papillary-mucinous neoplasms of the pancreas S.R. Hamilton, L.A. Aaltonen, World Health Organization classification of tumors 2000 IARC Press Lyon, France 237 241
5. R.P. Reddy, T.C. Smyrk, and M. Zapiach Pancreatic mucinous cystic neoplasm defined by ovarian stroma: demographics, clinical features, and prevalence of cancer Clin Gastroenterol Hepatol 2 2004 1026 1031
6. G. Zamboni, A. Scarpa, and G. Bogina Mucinous cystic tumors of the pancreas: clinicopathological features, prognosis, and relationship to other mucinous cystic tumors Am J Surg Pathol 23 1999 410 422
7. L.D. Thompson, R.C. Becker, and R.M. Przygodzki Mucinous cystic neoplasm (mucinous cystadenocarcinoma of lowgrade malignant potential) of the pancreas: a clinicopathologic study of 130 cases Am J Surg Pathol 23 1999 1 16
8. S. Andrejevic-Blant, M. Kosmahl, and B. Sipos Pancreatic intraductal papillary-mucinous neoplasms: a new and evolving entity Virchows Arch 451 2007 863
9. M. Kosmahl, U. Pauser, and K. Peters Cystic neoplasms of the pancreas and tumor-like lesions with cystic features: a review of 418 cases and a classification proposal Virchows Arch 445 2 2004 168 178
10. R. Salvia, C. Fernandez-del Castillo, and C. Bassi Main duct intraductal papillary-mucinous neoplasms of the pancreas: clinical predictors of malignancy and long term survival following resection Ann Surg 239 2004 678 685
11. T.A. Sohn, C.J. Yeo, and J.L. Cameron Intraductal papillary-mucinous neoplasms of the pancreas: an update experience Ann Surg 239 2004 788 797
12. W. Kimura, M. Makuuchi, and A. Kuroda Characteristics and treatment of mucin-producing tumor of the pancreas Hepatogastroenterology 45 1998 2001 2008
13. K. Yamao, K. Ohashi, and T. Nakamura The prognosis of intraductal papillary-mucinous tumors of the pancreas Hepatogastroenterology 47 2000 1129 1134
14. J.R. Rodriguez, R. Salvia, and S. Crippa Branch-duct intraductal papillary mucinous neoplasms: observations in 145 patients who underwent resection Gastroenterology 133 2007 72 77
15. J.Y. Jang, S.W. Kim, and S.E. Lee Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe? Ann Surg Oncol 15 2008 199 205
16. S. Partelli, C. Fernandez-Del Castillo, and C. Bassi Invasive intraductal papillary mucinous carcinomas of the pancreas: predictors of survival and the role of lymph node ratio Ann Surg 251 2010 477 482
17. T. Schnelldorfer, M.G. Sarr, and D.M. Nagorney Experience with 208 resections for intraductal papillary mucinous neoplasm of the pancreas Arch Surg 143 2008 639 646
18. K. Nagai, R. Doi, and A. Kida Intraductal papillary mucinous neoplasms of the pancreas: clinicopathologic characteristics and long-term follow-up after resection World J Surg 32 2008 271 278
19. N. Wasif, D.J. Bentrem, and J.J. Farrell Invasive intraductal papillary mucinous neoplasm versus sporadic pancreatic adenocarcinoma Cancer 116 2010 3369 3377
20. M. Niedergethmann, R. Grützmann, and R. Hildenbrand Outcome of invasive and noninvasive intraductal papillary-mucinous neoplasms of the pancreas (IPMN): a 10-year experience World J Surg 32 2008 2253 2260
21. S.T. Chari, D. Yadav, and T.C. Smyrk Study of recurrence after surgical resection of intraductal papillary-mucinous neoplasms of the pancreas Gastroenterology 123 5 2002 1500 1507
22. M. Sugiyama, Y. Izumisato, and N. Abe Predictive factors for malignancy in intraductal papillary-mucinous tumours of the pancreas Br J Surg 90 2003 1244 1249
23. R. Salvia, C. Fernández-del Castillo, and C. Bassi Main duct intraductal papillary-mucinous neoplasms of the pancreas: clinical predictors of malignancy and long term survival following resection Ann Surg 239 2004 678 687
24. Y. Kitagawa, T.A. Unger, and S. Taylor Mucus is a predictor of better prognosis and survival in patients with intraductal papillary mucinous neoplasms of the pancreas J Gastrointest Surg 7 2003 12 19
25. F. Maire, P. Hammel, and B. Terris Prognosis of malignant intraductal papillary mucinous tumors of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma Gut 51 2002 717 722
26. S.C. Kim, K.T. Park, and Y.J. Lee Intraductal papillary mucinous neoplasm of the pancreas: clinical characteristics and treatment outcomes of 118 consecutive patients from a single center J Hepatobiliary Pancreat Surg 15 2008 183 188
27. R. Doi, K. Fujimoto, and M. Wada Surgical management of intraductal papillary mucinous tumor of the pancreas Surgery 132 2002 80 85
28. C.P. Raut, K.R. Cleary, and G.A. Staerkel Intraductal papillary mucinous neoplasms of the pancreas: effect of invasion and pancreatic margin status on recurrence and survival Ann Surg Oncol 13 2006 582 594
29. M. Falconi, R. Salvia, and C. Bassi Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas Br J Surg 88 2001 376 381
30. K. Wada, R.A. Kozaked, and L.W. Traverso Outcomes following resection of invasive and noninvasive intraductal papillary mucinous neoplasm of the pancreas Am J Surg 189 2005 632 637
31. M. Sho, Y. Nakajima, and H. Kanehiro Pattern of recurrence after resection for intraductal papillary mucinous tumors of the pancreas World J Surg 22 1998 874 878
32. B. Terris, P. Ponsot, and F. Paye Intraductal papillary mucinous tumors of the pancreas confined to secondary ducts show less aggressive pathologic features as compared with those involving the main pancreatic duct Am J Surg Pathol 24 2000 1372 1377
33. S.M. Woo, J.K. Ryu, and S.H. Lee Survival and prognosis of intraductal papillary mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma Pancreas 36 2008 50 55
34. K. Shimada, Y. Sakamoto, and T. Sano Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: a clinicophatologic comparison with a common type of invasive ductal carcinoma Pancreas 32 2006 281 287
35. Y. Murakami, K. Uemura, T. Sudo, and Y. Hayashidani Invasive intraductal papillary-mucinous neoplasm of the pancreas: comparison with pancreatic ductal adenocarcinoma J Surg Oncol 100 1 2009 13 18
36. J.A. Waters, T. Schnelldorfer, and J.R. Aguilar-Saavedra Survival after resection for invasive intraductal papillary mucinous neoplasm and for pancreatic adenocarcinoma: a multi-institutional comparison according to American Joint Committee on cancer stage J Am Coll Surg 213 2 2011 275 283
37. H. Oettle, S. Post, and P. Neuhaus Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial J Am Med Assoc 297 2007 267 277
38. J.P. Neoptolemos, D.D. Stocken, and H. Friess A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer N Engl J Med 350 2004 1200 1210
39. J.P. Neoptolemos, D.D. Stocken, and C. Bassi Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection J Am Med Assoc 304 10 2010 1073 1081
40. D.D. Stocken, M.W. Büchler, and C. Dervenis Meta-analysis of randomised adjuvant therapy trials for pancreatic cancer Br J Cancer 92 2005 1372 1381
41. W.F. Regine, K.A. Winter, and R.A. Abrams Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma J Am Med Assoc 299 9 2008 1019 1026
42. M.M. Corsini, R.C. Miller, and M.G. Haddock Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo clinic experience (1975-2005) J Clin Oncol 26 2008 3511 3516
43. N.V. Adsay, C. Pierson, and F. Sarkar Colloid (mucinous noncystic) carcinoma of the pancreas Am J Surg Pathol 25 2001 26 42
44. Y. Sadakari, K. Ohuchida, and K. Nakata Invasive carcinoma derived from the nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type Surgery 147 2010 812 817
45. A.C. Yopp, and P.J. Allen Prognosis of invasive intraductal papillary mucinous neoplasms of the pancreas World J Gastrointest Surg 2 10 2010 359 362
46. M. D'Angelica, M.F. Brennan, and A.A. Suriawinata Intraductal papillary mucinous neoplasms of the pancreas: an analysis of clinicopathologic features and outcome Ann Surg 239 3 2004 400 408
47. K.C. Conlon Intraductal papillary mucinous tumors of the pancreas J Clin Oncol 23 20 2005 4518 4523
48. O. Turrini, J.A. Waters, and T. Schnelldorfer Invasive intraductal papillary mucinous neoplasm: predictors of survival and role of adjuvant therapy HPB (Oxford) 12 7 2010 447 455
49. R.E. Wilentz, and R.H. Hruban Pathology of cancer of the pancreas Surg Oncol Clin N Am 7 1998 43 65
50. J.Y. Jang, D.W. Hwang, and M.A. Kim Analysis of prognostic factors and a proposed new classification for invasive papillary mucinous neoplasms Ann Surg Oncol 18 2011 644 650
51. M. Worni, I. Akushevich, and B. Gloor Adjuvant radiotherapy in the treatment of invasive intraductal papillary mucinous neoplasm of the pancreas: an analysis of the surveillance, epidemiology, and end results registry Ann Surg Oncol 19 2012 1316 1323
52. M.J. Swartz, C.C. Hsu, and T.M. Pawlik Adjuvant chemoradiotherapy after pancreatic resection for invasive carcinoma associated with intraductal papillary mucinous neoplasm of the pancreas Int J Radiat Oncol Biol Phys 76 2010 839 844